✓ Medically reviewed by Dr. Anjmun Sharma, MD · Updated 2026-06-09

GLP-1 Medications and Antidepressants: Can You Take Them Together?

For most patients the combination is manageable under physician supervision, but it deserves an honest medication review and steady mood monitoring.

In most cases, yes. There is no major known drug interaction between GLP-1 medications such as semaglutide or tirzepatide and SSRIs or SNRIs, and many patients take both under medical supervision. The combination still deserves a physician's review, because GLP-1s slow stomach emptying, appetites change, and mood should be monitored throughout treatment. Never adjust either medication on your own.

A calm, peaceful moment of reflection

How GLP-1 medications and antidepressants interact

GLP-1 medications work on appetite hormones and slow how quickly the stomach empties. That slowing can subtly change how some oral medications are absorbed, especially around dose increases. For most SSRIs and SNRIs, which build steady levels in the blood over weeks, this is rarely a meaningful problem, but it is something your physician should know about and watch.

The two drug classes also share some early side effects, most notably nausea. If you felt queasy when you first started your antidepressant, mention it, since GLP-1 doses are started low and increased slowly to keep stomach side effects manageable.

What to tell your physician before starting

An honest medication history is the foundation of safe GLP-1 therapy. Before your first dose, your prescribing physician should know:

Ready to start?

$199 Skeptics’ Trial, see if it works for you

One month of medical-grade compounded semaglutide, the $119 doctor review, and a free B-12/lipotropic injection. No long-term commitment.

Start the 30-day trial

Some antidepressants are associated with weight gain, and your physician may factor that into your overall plan. Any change to either medication is always the physician's decision, made with you, never a swap you make on your own.

Mood monitoring during GLP-1 treatment

Regulators have reviewed reports of mood changes in people taking GLP-1 medications and so far have not confirmed that the medications cause them; research is ongoing. Even so, thoughtful monitoring makes sense. Significant weight loss changes routines, body image, and sometimes emotions, and any new medication deserves attention in the first months.

Report persistent sadness, new anxiety, sleep changes, loss of interest in things you enjoy, or any thoughts of self-harm to your physician right away. And do not stop your antidepressant to make room for a GLP-1; stopping an SSRI or SNRI abruptly can cause withdrawal symptoms and a return of the condition it treats.

How supervision works at New Hope Weight Loss

Every program at New Hope Weight Loss begins with a $119 medical review in which Dr. Anjmun Sharma, MD evaluates your full medication list, including antidepressants, before any prescription is written. Patients who qualify may be prescribed compounded semaglutide or compounded tirzepatide, with follow-ups that ask about mood, sleep, and energy, not just the number on the scale.

Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA. Brand versions such as Wegovy, Ozempic, Zepbound, and Mounjaro are FDA-approved medications, and the same antidepressant precautions apply to them as well.

What you can start today at New Hope Weight Loss

After a one-time $119 medical review with Dr. Sharma, eligible patients begin physician-supervised compounded semaglutide from $166 a month or compounded tirzepatide from $233 a month, with a $199 one-month Skeptics' Trial. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality. In person in Orange County and by telehealth across California and additional states.

Ready for an honest, physician-supervised plan?

A $119 review with Dr. Sharma is the first step, no pressure. Take the 2-minute quiz or call us.

Call (657) 837-3342

Frequently asked questions

Can I take semaglutide or tirzepatide with an SSRI like sertraline or escitalopram?

In most cases yes, since no major direct interaction is known, but the combination should always be reviewed and supervised by your prescribing physician. Tell them the exact antidepressant and dose before starting.

Do GLP-1 medications cause depression?

Regulators have reviewed reports of mood changes and have not confirmed that GLP-1 medications cause depression; research is ongoing. Physicians still screen mental health history and monitor mood during treatment as a precaution.

Will a GLP-1 change how my antidepressant is absorbed?

GLP-1 medications slow stomach emptying, which can subtly affect how some oral medications are absorbed. For most SSRIs and SNRIs this is rarely a meaningful issue, but your physician should know everything you take and monitor how you feel.

Should I stop my antidepressant before starting a GLP-1?

No. Stopping an SSRI or SNRI abruptly can cause withdrawal symptoms and a return of the condition it treats, and any medication change is always your physician's call. Most patients continue both medications together under supervision.

What mood changes should I report while on GLP-1 therapy?

Report persistent sadness, new or worsening anxiety, sleep problems, loss of interest in activities, or any thoughts of self-harm to your physician right away. Early reporting lets your care team adjust your plan safely.

This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.